Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $17.60, but opened at $18.66. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $17.76, with a volume of 7,747 shares traded.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on TLX shares. UBS Group raised their target price on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Monday, January 27th. William Blair reiterated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th.
Telix Pharmaceuticals Limited American Depositary Shares Trading Up 1.5 %
About Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
See Also
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- Following Congress Stock Trades
- FedEx Delivers Another Crushing Blow to Its Stock Price
- 3 Dividend Kings To Consider
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Do ETFs Pay Dividends? What You Need to Know
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
